Carl Walkey

Carl Walkey

Company: Neoleukin Therapeutics

Job title: Senior Vice President - Corporate Development


Formal Closing Panel Discussion: Predicting Future Directions For Cytokine Therapeutic Development & Treatment 5:00 pm

Read more

day: Day Two

Group Panel Discussion: Next Steps: From Concept to Therapy – Considerations for Successfully Applying Strategies Learnt To Optimize Your Cytokine Therapy 5:30 pm

The importance and practical implications of optimizing toxicity, dosing, scheduling & related considerations – how far have we come & what do we need to remember when designing cytokine therapies Tips, pitfalls & lessons learnt from optimizing toxicity & dosing Considerations for cytokine delivery design/methods/concepts Developing a biomarker alongside a therapy – how should we…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.